This mechanism is also responsible for the diminished resistance to anti-PD-1 immunotherapy in melanoma, suggesting LSD1 as a promising immunotherapy target.171 It seems that H3K9 methylation regulated by SETDB1, LSD1, and JMJD2C plays contrary roles in melanoma carcinogenesis and development respectively. Here, KDM4C is linked to melanoma.